PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Short Interest Update

PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 33,300 shares, a decrease of 17.4% from the October 15th total of 40,300 shares. Based on an average trading volume of 20,600 shares, […]

Leave a Reply

Your email address will not be published.

Previous post Rhumbline Advisers Grows Holdings in Lattice Semiconductor Co. (NASDAQ:LSCC)
Next post Reviewing Tenaris (NYSE:TS) & Akastor ASA (OTCMKTS:AKKVF)